Disperazol Pharma ApS
CVR 44265761 · Private limited company (ApS) · Active · Low risk
Disperazol Pharma ApS is a Private limited company (ApS), founded on , based in Humlebæk. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.0% over the next 12 months, which is 0.7 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (8 Aug 2025) shows equity of DKK 30k and a net result of DKK -42k.
Bankruptcy risk for Disperazol Pharma ApS
0.7 × the average (1.41%) · higher risk than 72% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44265761
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Boserupvej 206
3050 Humlebæk - Municipality
- Fredensborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 26k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 60.4% |
| Current ratio | 253% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -50k | DKK 40k |
| Net profit | DKK -42k | DKK 32k |
| Equity | DKK 30k | DKK 72k |
| Total assets | DKK 50k | DKK 81k |
| Cash | DKK 41k | – |
| Short-term debt | DKK 20k | – |
| Tax owed | DKK 8,932 | – |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 9 Aug 2024 – 8 Aug 2025 | 183 | ||
| 1 Sep 2023 – 8 Aug 2024 | 315 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Founder | Michael Christian Givskov | Current | |
| Founder | Carl Jörg Michael Graz | Current |
Address history (0 moves)
| Boserupvej 206, 3050 Humlebæk |
Similar companies in Fredensborg
- INMOLD A/S Nivå
- POALIS A/S Fredensborg
Questions and answers about Disperazol Pharma ApS
Has Disperazol Pharma ApS gone bankrupt?
No, Disperazol Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Disperazol Pharma ApS?
Our model estimates a bankruptcy risk of 1.0% over the next 12 months (low risk), which is 0.7 times the average for Danish companies.
When was Disperazol Pharma ApS founded?
Disperazol Pharma ApS was founded on 22 August 2023.
What is the equity of Disperazol Pharma ApS?
Equity was DKK 30k according to the annual report for the period ending 8 August 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.